Vesuvius Intrinsic Value
VESUVIUS • Industrial Products
Current Stock Price
₹463.15
Primary Intrinsic Value
₹471.60
Market Cap
₹926.3 Cr
+71.7%
Upside
Median Value
₹795.41
Value Range
₹139 - ₹1158
Assessment
Trading Below Calculated Value
Safety Margin
41.8%
VESUVIUS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹471.60 | ₹377.28 - ₹565.92 | +1.8% | EPS: ₹39.30, Sector P/E: 12x |
| Book Value Method | asset | ₹715.50 | ₹643.95 - ₹787.05 | +54.5% | Book Value/Share: ₹715.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹865.20 | ₹778.68 - ₹951.72 | +86.8% | Revenue/Share: ₹1081.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹926.30 | ₹833.67 - ₹1018.93 | +100.0% | EBITDA: ₹419.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1157.88 | ₹926.30 - ₹1389.46 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹138.94 | ₹125.05 - ₹152.83 | -70.0% | EPS Growth: 4.0%, Fair P/E: 3.2x |
| Growth Adjusted P/E | growth | ₹337.98 | ₹304.18 - ₹371.78 | -27.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹926.30 | ₹833.67 - ₹1018.93 | +100.0% | ROE: 18.4%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹795.41 | ₹715.87 - ₹874.95 | +71.7% | EPS: ₹39.30, BVPS: ₹715.50 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
VESUVIUS Intrinsic Value Analysis
What is the intrinsic value of VESUVIUS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Vesuvius (VESUVIUS) is ₹795.41 (median value). With the current market price of ₹463.15, this represents a +71.7% variance from our estimated fair value.
The valuation range spans from ₹138.94 to ₹1157.88, indicating ₹138.94 - ₹1157.88.
Is VESUVIUS undervalued or overvalued?
Based on our multi-method analysis, Vesuvius (VESUVIUS) appears to be trading below calculated value by approximately 71.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 29.32 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 18.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.17x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Vesuvius
Additional stock information and data for VESUVIUS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹258 Cr | ₹142 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹82 Cr | ₹64 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹129 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹27 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2020 | ₹102 Cr | ₹-150 Cr | Positive Operating Cash Flow | 6/10 |